Latest Probes, Restatements, and Class Actions
Compliance Week › Vol. 6 Nbr. 70, November 2009
Linked as:
Summary
Elan Corp. Subpoenaed by SEC-Elan Corp. Plc recently announced it has received a subpoena from the Securities and Exchange Commission seeking information about disclosures made last year in regard to the company's multiple-sclerosis drug Tysabri and an Alzheimer's disease drug, both of which improved Elan shares. Elan's partner in creation of the experimental Alzheimer's drug, said they are cooperating with the SEC and working to provide the Commission with more information.
See the full content of this document
Extract
Latest Probes, Restatements, and Class Actions
ABOUT DATA & DISCLOSURES
Every week, Compliance Week tracks a number of corporate disclosures for its subscribers. Among the types of disclosures tracked: regulatory probes and internal investigations; restatements and filing delays; class-action lawsuits and settlements; auditor changes; and more. A sampling of recent disclosures is below; for the latest information-as well as searchable databases of corporate charters, material definitive agreements, internal control disclosures, and mor...See the full content of this document
(Copyright 2011)
Provided by ProQuest LLC. All Rights Reserved.
Content not included in vLex Global Academic product.
Sponsored links
